UK markets closed

Indiva Limited (NDVAF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0600-0.0067 (-10.04%)
At close: 03:47PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0667
Open0.0540
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0540 - 0.0600
52-week range0.0110 - 0.0950
Volume102,489
Avg. volume43,260
Market cap11.718M
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Indiva Announces Second Private Placement Under the Listed Issuer Financing Exemption up to $4,094,000

    LONDON, Ontario, March 12, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce a second private placement offering pursuant to the listed issuer financing exemption of a minimum of 10,940,000 units of the Company (each, a "Unit") and a maximum of 40,940,000 Units, at a price of $0.10 per Unit, for minimum gross proceeds to the Company of $1,094,000 and maximum gross proceeds of $4,094,000 (the "Offering").

  • Business Wire

    Indiva Announces Closing of the First Tranche of Life Offering & Provides Update on Previously Announced Private Placement

    LONDON, Ontario, March 04, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce the closing of the first tranche (the "First Tranche") of its previously announced private placement offering pursuant to the listed issuer financing exemption pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 56-106"), first announced on January 22, 2024, and then amended and restated on February 28, 2024

  • Business Wire

    Indiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 Million

    LONDON, Ontario, February 28, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce that, it has filed an amended and restated offering document dated February 28, 2024 (the "Amended and Restated Offering Document") in connection with its previously announced non-brokered private placement (the "LIFE Offering") pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectu